CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Grant or award Chief Medical Officer acquired 12,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 7,500 shares (grant or award)
- 4 Grant or award Chief Development Officer acquired 12,000 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Director sold 8,400 shares at an average $25.30 ($212,555)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale President and CEO sold 24,846 shares at $24.60 ($611,105)
- 424B5 Offering Prospectus
- 8-K Event Other events
Page 20 of 36 · 707 filings